This chemical is primarily used in the development of targeted cancer therapies. It functions as a potent inhibitor of specific tyrosine kinases, which are enzymes involved in the signaling pathways that promote cancer cell growth and survival. By blocking these kinases, it helps to halt the proliferation of cancer cells and can induce apoptosis, or programmed cell death. Its application is particularly relevant in treating non-small cell lung cancer (NSCLC) and other solid tumors where the targeted kinases are overactive. The compound is often incorporated into pharmaceutical formulations designed for oral administration, ensuring effective delivery to the affected tissues. Ongoing research continues to explore its potential in combination therapies and its efficacy against resistant forms of cancer.